Terms: = Endocrine gland cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17
16 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic silencing
Du Q; Zhang M; Gao A; He T; Guo M
Cancer Biol Ther; 2024 Dec; 25(1):2302924. PubMed ID: 38226836
[TBL] [Abstract] [Full Text] [Related]
3. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract] [Full Text] [Related]
4. KRAS Wild-Type Pancreatic cancer: Decoding Genomics, Unlocking Therapeutic Potential.
Kato H; Ellis H; Bardeesy N
Clin Cancer Res; 2023 Nov; 29(22):4527-4529. PubMed ID: 37695631
[TBL] [Abstract] [Full Text] [Related]
5. MYH10 Combines with myh9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian cancer Carcinogenesis, Progression, and Cisplatin Resistance.
Liu L; Chen C; Liu P; Li J; Pang Z; Zhu J; Lin Z; Zhou H; Xie Y; Lan T; Chen ZS; Zeng Z; Fang W
Adv Sci (Weinh); 2023 May; 10(14):e2203423. PubMed ID: 36929633
[TBL] [Abstract] [Full Text] [Related]
6. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2.
Meng L; Zhang Y; Wu P; Li D; Lu Y; Shen P; Yang T; Shi G; Chen Q; Yuan H; Ge W; Miao Y; Tu M; Jiang K
Mol Cancer; 2022 Jun; 21(1):121. PubMed ID: 35650603
[TBL] [Abstract] [Full Text] [Related]
7. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.
Balouchi-Anaraki S; Ahmadvand S; Safaei A; Ghaderi A
Iran Biomed J; 2021 Sep; 25(5):310-22. PubMed ID: 34425650
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of circ_NEK6 Decreased
Chen F; Yin S; Feng Z; Liu C; Lv J; Chen Y; Shen R; Wang J; Deng Z
Technol Cancer Res Treat; 2021; 20():15330338211004950. PubMed ID: 33759638
[TBL] [Abstract] [Full Text] [Related]
9. CRLF1-myh9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis.
Yu ST; Sun BH; Ge JN; Shi JL; Zhu MS; Wei ZG; Li TT; Zhang ZC; Chen WS; Lei ST
Front Endocrinol (Lausanne); 2020; 11():535. PubMed ID: 32982961
[TBL] [Abstract] [Full Text] [Related]
10. Eltrombopag to allow chemotherapy in a patient with myh9-related inherited thrombocytopenia and pancreatic cancer.
Paciullo F; Bury L; Gresele P
Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
[TBL] [Abstract] [Full Text] [Related]
11. miR-6089/myh9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
[TBL] [Abstract] [Full Text] [Related]
12. Targeting Mechanoresponsive Proteins in Pancreatic cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
[TBL] [Abstract] [Full Text] [Related]
13. Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid cancer.
Hińcza K; Kowalik A; Kowalska A
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31247975
[TBL] [Abstract] [Full Text] [Related]
14. myh9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
Wang Y; He H; Li W; Phay J; Shen R; Yu L; Hancioglu B; de la Chapelle A
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):474-479. PubMed ID: 28049826
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacological activation of myosin II paralogs to correct cell mechanics defects.
Surcel A; Ng WP; West-Foyle H; Zhu Q; Ren Y; Avery LB; Krenc AK; Meyers DJ; Rock RS; Anders RA; Freel Meyers CL; Robinson DN
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1428-33. PubMed ID: 25605895
[TBL] [Abstract] [Full Text] [Related]
16. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis.
Birner P; Schindl M; Obermair A; Plank C; Breitenecker G; Kowalski H; Oberhuber G
Anticancer Res; 2000; 20(5A):2981-5. PubMed ID: 11062711
[TBL] [Abstract] [Full Text] [Related]
